2023: A Year of Expansion and Consolidation
As the year draws to a close, The Ganesha Lab reflects on the transformative journey of 2023, a period marked by substantial growth and consolidation. The twelve months have been characterized by numerous milestones, shaping the course of our history.
One significant aspect of our evolution has been the integration of three new team members, bringing both professional expertise and a sense of unity to our close-knit group. In May, Carolina Marió assumed the role of Program Coordinator, followed by the addition of Matías Rothhammer, Portfolio Manager AgriFood and Juan Pablo García as Venture Capital Associate in October.
The seamless integration of Carolina, Matias, and Juan Pablo into our team has been pivotal, with their dedication and contributions evident in every activity they have engaged in at The Ganesha Lab. We extend our gratitude for their alignment with our mission, transforming science into a good business impacting the lives of millions of people globally.
In September, we publicly launched The Ganesha Fund, our investment arm with a mission to support approximately 30 pre-seed and seed-stage startups addressing issues related to human and planetary health.
The fund aims to provide an average investment of USD $250,000 per startup. This Delaware-based entity is led by Markus Schreyer and Juan Carlos Muñoz-Boudeguer, Managing Partners, alongside Antonio Gil Nievas, as venture partner. The three partners combine over 75 years of experience in biotech business, technology, entrepreneurships and investment.
The fund has already made its inaugural investments on of which is Delee. A Mexican startup revolutionizing early cancer diagnostics via a Liquid Biopsie platform enabling high performance isolation of Circulating Tumor Cells. Notably, Delee arrived to us from Y-Combinator and has established partnerships with Stanford University for their first pilot.
Confident in the potential impact, we believe this new venture will significantly contribute to the advancement of Latin American biotechnology, emerging as a crucial resource for science-based startups across the subcontinent.
November witnessed the second edition of BIOHUNT Summit in Miami, featuring 21 startups from Argentina, Uruguay, Chile, Brazil, Colombia, Mexico, and Costa Rica. The event drew over 150 investors and experts, representing delegations from Europe, the United States, and Latin America.
Respected keynote speakers, including Stephen Chambers, General Partner of SOSV; Moishe Mana, Chairman and CEO and Etienne Gillard, Head of Ventures of Mana Tech; and Michael Burtov, renowned U.S. entrepreneur and former Shark Tank judge, provided insights into the development of Latin American biotechnology and its potential impact in the years to come.
As we bid farewell to 2023, marked by these remarkable milestones, we eagerly anticipate 2024, poised for further improvement and continued growth. Join us on this exciting journey!